Patents Assigned to Biocure Limited
  • Patent number: 6475790
    Abstract: A multicellular in vitro assay which models the combined stages of angiogenesis is disclosed. The assay permits the evaluation of drug candidates for their potential utility in treating pathological conditions such as chronic dermal ulcers, tumors, diabetic retinopathy, psoriasis and inflammation.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: November 5, 2002
    Assignee: Biocure Limited
    Inventors: Eileen T. Grant, Graham T. Bell, Stephen Bloor
  • Patent number: 6225118
    Abstract: A multicellular in vitro assay for modeling the combined stages of angiogenesis namely the proliferation, migration and differentiation stages of cell development, wherein the assay comprises providing a dual culture of endothelial cells together with another cell-type exhibiting interaction therewith to display the combined stages of angiogenesis in vitro.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: May 1, 2001
    Assignee: Biocure Limited
    Inventors: Eileen T. Grant, Graham T. Bell, Stephen Bloor
  • Patent number: 5684166
    Abstract: Compounds having utility in medicine in countering cellular malfunction e.g. in conditions embraced by the general term "cancer", which compounds normally exist us a keto-enol tautomeric pair, the racetalc keto form of which is rapresented by formula (Ia), wherein R is a hydrogen, lower alkyl, acyl, or another functional group of up to 6 carbons including at least one hetero atom, which atom may be directly bonded to the .beta.-carbon, which compound may be in the acylic form shown or in a cyclic form as equilibrium keto-enol tautomer derivatives and anomeric forms thereof, including enantiomers when R is hydrogen and diastereoisomers when R is another group.
    Type: Grant
    Filed: April 4, 1996
    Date of Patent: November 4, 1997
    Assignee: Biocure Limited
    Inventor: Neil Geddes Clarkson Hendry